Chemcon Speciality Chemicals has announced its audited financial results for the quarter and financial year ended March 31, 2026. The company reported a net profit of ₹6.4 crore for the quarter ended March 31, 2026, compared to ₹3.9 crore in the corresponding period of the previous year. For the full financial year 2025-26, the net profit stood at ₹23.6 crore, while revenue from operations reached ₹240 crore. The results were published in newspapers on May 22, 2026, pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance

Revenue from operations for the year ended March 31, 2026, increased to ₹240 crore from ₹207.4 crore in the previous year. Total income for the year rose to ₹255.4 crore. The company's basic earnings per share (EPS) for the year was recorded at ₹6.44. On a quarterly basis, Q4 revenue came in at ₹75.4 crore compared to ₹54.9 crore in the same period of the previous year, reflecting strong year-on-year growth.

The following table summarises the key financial metrics for the quarter and full year:

EBITDA Performance

Chemcon Speciality Chemicals also reported improved operational profitability for the quarter. Q4 EBITDA stood at ₹8.9 crore compared to ₹5.8 crore in the corresponding period of the previous year. The EBITDA margin expanded to 11.8% from 10.5% year-on-year, indicating improved cost efficiency and operating leverage during the quarter.

Strategic Developments

During the quarter, both the Organic and Inorganic Chemicals segments delivered improved performance, driven by higher volumes and better realizations across key products. Newer products such as Bromobenzene and 2-Bromo have seen encouraging response from end user industries like pharmaceutical, agrochemical, aromatic chemical, and other end-user industries. On the strategic front, the acquisition of Shivam Petrochem Industries through a slump sale is progressing well, with integration activities and license transfers nearing completion. The acquired business is expected to begin contributing to revenues in the coming quarters and will further strengthen the company's presence across bulk drugs, chemical intermediates, solvents, and specialty chemicals.

Auditor and Board Appointments

M/s Shah Mehta & Bakshi, Chartered Accountants, audited the financial results and issued an audit report with an unmodified opinion. Additionally, the board approved the re-appointment of M/s Chetan Gandhi & Associates as Cost Auditors and M/s Kulin Shah & Associates as Internal Auditors for the financial year 2026-27.

Chemcon speciality chemicals Limited has filed its quarterly regulatory compliance certificate with the Bombay Stock Exchange and National Stock Exchange of India for the quarter ended March 31, 2026. The submission fulfills the company's obligations under SEBI's depositories regulations framework.

Regulatory Compliance Filing

The company submitted the confirmation certificate as required under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. Company Secretary and Compliance Officer Shahilkumar Kapatel signed the filing on April 10, 2026, ensuring timely submission to both stock exchanges.

Registrar Confirmation

MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, serves as Chemcon's registrar and share transfer agent. The registrar issued the confirmation certificate on April 3, 2026, verifying proper handling of dematerialised securities during the quarter.

The certificate confirms that securities received from depository participants for dematerialisation were properly processed and that security certificates were mutilated and cancelled after due verification. The registrar also confirmed that depositories' names were substituted in the register of members as registered owners within prescribed timelines.

Corporate Governance

This filing demonstrates Chemcon's commitment to maintaining regulatory compliance and corporate governance standards. The quarterly certification process ensures transparency in the handling of dematerialised securities and adherence to SEBI's regulatory framework for listed companies.

The company maintains its listing on both major Indian stock exchanges, with securities traded under the symbol CHEMCON on NSE and stock code 543233 on BSE. Regular compliance filings like this certificate help maintain investor confidence and regulatory standing.